Novo Nordisk A/S
Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with pre-diabetes compared to […]
Read More
Novo Nordisk vs. Eli Lilly: Analysts weigh in as the obesity-drug battle heats up
COPENHAGEN, Denmark — Analysts are paying close attention to Novo Nordisk and Eli Lilly , as the battle to dominate the weight loss drug market heats up. Europe’s largest company Novo Nordisk has dominated headlines since anti-obesity medication took off. It produces weight-loss and diabetes drugs Wegovy and Ozempic and saw its shares rise exponentially […]
Read More
S&P 500 will be closer to 6,000 by year-end, Morgan Stanley’s Slimmon says, naming stocks to buy
Markets have been very rocky lately, but Morgan Stanley Investment Management’s Andrew Slimmon has an idea of how they could go from here. He says the market could “be consistent with 2023,” after much volatility in the past few weeks. In late July, both the S & P 500 and the Nasdaq dived to a […]
Read More
What’s next for the Biden administration’s Medicare drug price negotiations
U.S. President Joe Biden and Vice President Kamala Harris walk out together, at an event on Medicare drug price negotiations, in Prince George’s County, Maryland, U.S., August 15, 2024. Ken Cedeno | Reuters The Biden administration on Thursday reached a milestone in Democrats’ decades-long quest to use Medicare to drive down prescription drug costs, releasing […]
Read More
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday will release prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and […]
Read More
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Novo Nordisk and Eli Lilly have so far dominated the booming market for a class of weight loss and diabetes drugs. […]
Read More
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine whether their insurance covers a buzzy class of weight loss and diabetes drugs called GLP-1s. Most insurance plans cover GLP-1s when they are used to treat diabetes, so those patients can usually avoid the roughly […]
Read More
Eli Lilly reports earnings Thursday. Here’s what Wall Street is watching
Investors want to know whether Eli Lilly is seeing the same pricing pressures on its blockbuster weight loss drug Zepbound that Novo Nordisk experienced with its competing drug Wegovy in the second quarter. Novo Nordisk shocked investors on Wednesday when its latest results fell short of Wall Street’s expectations. Shares are reeling, down 8%, after […]
Read More
Stocks making the biggest moves midday: Fortinet, Shopify, Lyft and more
Check out the companies making headlines in midday trading. Fortinet – The cybersecurity stock was the biggest advancer in the S & P 500 on Wednesday, surging 26% after Fortinet posted a strong second-quarter report, as well as upbeat current quarter guidance. The cybersecurity company posted adjusted quarterly earnings of 57 cents per share on […]
Read More
Stocks making the biggest moves premarket: Disney, Airbnb, Rivian, Amgen and more
Check out the companies making headlines before the bell. Disney — Shares were down about 1% after the media giant reported quarterly results that beat analyst expectations, thanks in part to strong performance at its streaming unit. The company earned $1.39 per share, excluding items, on revenue of $23.16 billion. Analysts expected a profit of […]
Read More